drug · unknown
patient view →prabotulinumtoxin A
Phase 2updated 2mo agoby $AEON AEON Biopharma, Inc.🔗 ChEMBL
Phase 2community read0 votes
Unknown drug with a maximum clinical stage of Approval (across all indications), with an approval for skin aging and 2 investigational indications.
targets
Synaptosomal-associated protein 25
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that